Lyell Immunopharma, Inc. (LYEL)

23.07 +0.36 (+1.59%) USD  |  NASDAQ  |  Feb 24, 16:00
23.00 -0.06 (-0.28%) After-Hours: 20:00
More

Lyell Immunopharma Cash from Other Financing Activities (Quarterly)

Cash from Other Financing Activities (Quarterly) Chart

View Cash from Other Financing Activities (Quarterly) for LYEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Other Financing Activities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash from Other Financing Activities (Quarterly) Range, Past 5 Years

View Cash from Other Financing Activities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Other Financing Activities (Quarterly) Benchmarks

View Cash from Other Financing Activities (Quarterly) Benchmarks
Start Trial
Insmed, Inc. --
Nektar Therapeutics --
GT Biopharma, Inc. --
Regeneron Pharmaceuticals, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade